In a 13‑year‑11‑month‑old boy with multifocal ankle and hind‑foot bone‑marrow edema, normal inflammatory markers, normal fecal calprotectin and a good response to celecoxib, is it typical for chronic non‑bacterial osteitis patients to have pain that worsens at rest and improves with activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pain Pattern in Chronic Non-Bacterial Osteitis (CNO)

No, the pain pattern you describe—worsening at rest and improving with activity—is not typical for CNO and should prompt investigation of alternative pain sources. CNO characteristically presents with inflammatory bone pain that has opposite characteristics: pain irrespective of motion or pain during the night, which are hallmark inflammatory features 1.

Characteristic Pain Pattern in CNO

The 2025 expert consensus guidelines from the Annals of the Rheumatic Diseases specifically describe CNO pain as having inflammatory properties 1:

  • Atraumatic bone pain persisting for over 6 weeks 1
  • Pain irrespective of motion 1
  • Pain during the night 1

These inflammatory pain characteristics are fundamentally different from mechanical pain patterns that worsen with activity and improve with rest.

Clinical Implications for Your Patient

In this 13-year-old boy with multifocal ankle and hindfoot bone marrow edema, normal inflammatory markers, normal fecal calprotectin, and good response to celecoxib, the pain pattern improving with activity suggests you should investigate other causes before attributing symptoms solely to CNO 1.

The guidelines specifically address this scenario:

When clinical symptoms exist without clear radiological disease activity correlation, the expert panel recommends considering patients as "probably inactive CNO" and first investigating other causes of pain 1.

Alternative pain sources to consider include 1:

  • Myalgia 1
  • Central sensitization 1
  • Neuropathic pain 1
  • Pain from structural changes (such as mechanical issues related to ankylosis) 1

Disease Activity Assessment

The guidelines emphasize that active CNO requires both clinical symptoms AND radiological disease activity to warrant treatment 1. Your patient has:

  • ✓ Radiological findings (bone marrow edema on MRI) 1
  • ✓ Clinical symptoms (pain) 1
  • ✓ Good response to celecoxib (first-line NSAID/COXIB therapy) 1

However, the atypical pain pattern (improving with activity rather than worsening at night or being motion-independent) raises concern that the pain may not be primarily inflammatory in nature 1.

Clinical Pitfalls to Avoid

Do not assume all pain in a patient with radiological bone marrow edema is due to CNO 1. The guidelines explicitly warn that bone marrow edema can have multiple etiologies, and pain patterns help distinguish inflammatory from non-inflammatory causes 2.

Normal inflammatory markers do not exclude CNO, as these are only included "if applicable" in disease activity assessment 1. However, combined with atypical pain characteristics, this strengthens the case for investigating alternative diagnoses 1.

Normal fecal calprotectin is reassuring as it makes inflammatory bowel disease less likely as a contributing factor 3, 4, though this is not directly related to CNO activity assessment.

Treatment Response Evaluation

Since your patient is responding well to celecoxib (200-400 mg/day is the recommended dosing for inflammatory conditions) 1, 5, continue current therapy and re-evaluate at 2-4 weeks per guideline recommendations 1.

If sufficient response continues, re-evaluate at 12 weeks and consider tapering or on-demand treatment 1. The good response to NSAIDs supports an inflammatory component, even if the pain pattern is atypical 1.

If pain persists despite adequate NSAID therapy, this would constitute insufficient response and warrant either NSAID rotation or advancement to second-line treatment with intravenous bisphosphonates (preferred) or TNF inhibitors 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.